Re: Another CPI for IMO-2125 to help?
More color on the new approval:
" About 1,600 people are diagnosed with Merkel cell carcinoma (MCC) every year in the U.S., the FDA said in a statement about the approval. In more than 30% of those patients, the disease has metastasized, or spread beyond the skin to other parts of the body. Bavencio is approved to treat patients with metastatic disease, and it’s the only drug specifically blessed to do so. "
Metastic skin cancer. Accessible for intratumoral injection and need for improved survival and the abscopal effect in the only CPI thus far approved for metastatic disease. Sounds right up the IMO-2125 alley.